Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma
Authors:
- D YangDYD Yang
- S LiSLS Li
- Y GaoYGY Gao
- R JiangRJR Jiang
- L DengLDL Deng
- F R FrankelFFF R Frankel
- B SunBSB Sun
- 19 September 2011
- journal article
- Published by Springer Nature in Oncogene
- Vol. 31 (17) , 2140-2152
Abstract
Live attenuated Listeria monocytogenes (LM) is a promising bacterial vector able to induce a T-cell response to tumor-associated antigens and demonstrates great potential for use in vaccine development. A novel recombinant LM-based vaccine (Lmdd (LM ΔdalΔdat)-MPFG (multiple peptide fusing genes)) was developed with the ability to express and secrete hepatocellular carcinoma (HCC)-related tumor-associated antigens fragments due to the insertion of hepatitis B virus (HBV)-X protein (HBx)-derived epitopes HBx(52-60) and HBx(140-148), the universal T-helper epitope, alpha-fetoprotein (AFP) epitope AFP(158-166), and melanoma antigen gene (MAGE)-3(271-279) into the HBV core protein. Following immunization with the Lmdd-MPFG vaccine, macrophages exhibited uptake of the bacteria; the vaccine was then nearly cleared 3 days after the first administration. It disappeared even more quickly following subsequent vaccinations. However, recombinant Lmdd-MPFG allowed for the full development of an antitumor response towards the human leukocyte antigen (HLA)-A0201 epitopes of MPFG. Each epitope stimulated an augmented T-cell proliferation and enhanced the supernatant level of interferon (IFN)-γ in vitro. In addition, IFN-γ-producing CD8(+) T cells as well as in vivo cytolytic activity were significantly increased in HLA-A2 transgenic mice. Additionally, the Lmdd-MPFG developed a strong antitumor response, as indicated by the significant resistance of immunized mice to MPFG-positive Hepa1-6 cell challenge in both a prophylactic and therapeutic setting. Tumor regression was accompanied by an enhanced cytotoxic T lymphocyte response and a decrease of regulatory T cells in the tumor. Collectively, these results suggest that utilizing attenuated LM as a vaccine vector, able to carry the MPFG gene, presents a potentially feasible strategy for prevention of HCC.Keywords
This publication has 53 references indexed in Scilit:
- A live attenuated Listeria monocytogenes vaccine vector expressing SIV Gag is safe and immunogenic in macaques and can be administered repeatedlyVaccine, 2011
- Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinomaCarcinogenesis, 2010
- Increased Hematopoietic Cells in the mertk−/− Mouse Peritoneal Cavity: A Result of Augmented MigrationThe Journal of Immunology, 2010
- Toll-Like Receptor 2- and MyD88-Dependent Phosphatidylinositol 3-Kinase and Rac1 Activation Facilitates the Phagocytosis ofListeria monocytogenesby Murine MacrophagesInfection and Immunity, 2010
- Differences in Tumor Regulatory T-Cell Localization and Activation Status Impact Patient OutcomeCancer Research, 2009
- Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T CellsCancer Research, 2009
- Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer ImmunotherapyClinical and Vaccine Immunology, 2009
- KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunityJournal of Clinical Investigation, 2008
- A Listeria monocytogenes Mutant Defective in Bacteriophage Attachment Is Attenuated in Orally Inoculated Mice and Impaired in Enterocyte Intracellular GrowthInfection and Immunity, 2008
- Listeriolysin O derived fromListeria monocytogenesinhibits the effector phase of an experimental allergic rhinitis induced by ovalbumin in miceClinical and Experimental Immunology, 2006